Amylyx Pharmaceuticals

$18.52 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals Inc, located in Cambridge, Massachusetts, is a pharmaceutical company. It is focused on the development of therapeutics for the treatment of neurodegenerative disorders. The Company was founded in 2013.

Stock Analysis

last close $20.29
1-mo return -
3-mo return -
avg daily vol. 468.56T
52-week high 23.16
52-week low 16
market cap. $1.2B
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. -
inst own. 31.9%

Subscribe now for daily local and international financial news